Surgery – Body inserted urinary or colonic incontinent device or...
Reexamination Certificate
1999-01-15
2001-05-29
Winakur, Eric F. (Department: 3736)
Surgery
Body inserted urinary or colonic incontinent device or...
Reexamination Certificate
active
06238335
ABSTRACT:
BACKGROUND OF THE INVENTION
This invention pertains to the treatment of gastroesophageal reflux disease and, more particularly, to the treatment of gastroesophageal reflux disease by augmenting tissue in the upper gastrointestinal tract.
Gastroesophageal reflux disease (GERD) is a failure of the anti-reflux barrier, allowing abnormal reflux of gastric contents into the esophagus. Gastroesophageal reflux disease is a disorder which is usually characterized by a defective lower esophageal sphincter (LES), a gastric emptying disorder with or without failed esophageal peristalsis. The disease usually manifests itself during “transient lower esophageal sphincter relaxation” episodes, the frequency of which is greatly increased in patients who reflux. Medical or drug therapy is the first line of management for gastroesophageal refluxes. However, drug management does not address the condition's mechanical etiology. Thus symptoms recur in a significant number of sufferers within one year of drug withdrawal. In addition, while medical therapy may effectively treat the acid-induced symptoms of gastroesophageal reflux disease, esophageal mucosal injury may continue due to ongoing alkaline reflux. Since gastroesophageal reflux disease is a chronic condition, medical therapy involving acid suppression and/or promotility agents may be required for the rest of a patient's life.
The expense and psychological burden of a lifetime of medication dependence, undesirable life style changes, uncertainty as to the long term effects of some newer medications and the potential for persistent mucosal changes despite symptomatic control, all make surgical treatment of gastroesophageal reflux disease an attractive option. Unfortunately, surgical intervention is a major operation with all attendant morbidities, mortality and risk of failure requiring further surgery in the case of over-correction. Laparoscopic surgery requires a very high level of skill and special training for it to be successful.
Minimally invasive approaches have been tried for treating gastroesophageal reflux disease, but have had only transient effects. Such approaches include the injection of sclerosing agents at the level of the gastric cardia. Injections of other biodegradable substances have been tried, but have proven to provide only a short duration of activity.
OBJECTS AND SUMMARY OF THE INVENTION
In general, it is an object of the present invention to provide a minimally invasive method and apparatus for treating gastroesophageal reflux disease.
Another object of the invention is to provide a method and apparatus of the above character for injecting a nonbiodegradable material in the wall forming the esophagus and/or stomach in the vicinity of the lower esophageal sphincter for bulking such wall.
Another object of the invention is to provide a method and apparatus of the above character in which the material is injected as at least one solution and thereafter forms a solid.
Another object of the invention is to provide a method and apparatus of the above character in which the at least one solution includes a solution from which a nonbiodegradable solid precipitates.
Another object of the invention is to provide a method and apparatus of the above character in which the solution includes a biocompatible polymer and a biocompatible solvent.
Another object of the invention is to provide a method and apparatus of the above character in which one or more implants is formed in the wall.
Another object of the invention is to provide a method and apparatus of the above character which is reversible.
Another object of the invention is to provide a method and apparatus of the above character in which an aqueous or physiologic solution is introduced into the wall to condition the wall.
Additional objects and features of the invention will appear from the following description from which the preferred embodiments are set forth in detail in conjunction with the accompanying drawings.
REFERENCES:
patent: 3094122 (1963-06-01), Gauthier et al.
patent: 3204634 (1965-09-01), Koehn
patent: 4271827 (1981-06-01), Angelchik
patent: 4351333 (1982-09-01), Lazarus et al.
patent: 4424208 (1984-01-01), Wallace et al.
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4773393 (1988-09-01), Haber et al.
patent: 4803075 (1989-02-01), Wallace et al.
patent: 4837285 (1989-06-01), Berg et al.
patent: 5007940 (1991-04-01), Berg
patent: 5067965 (1991-11-01), Ersek et al.
patent: 5116387 (1992-05-01), Berg
patent: 5158573 (1992-10-01), Berg
patent: 5204382 (1993-04-01), Wallace et al.
patent: 5258028 (1993-11-01), Ersek et al.
patent: 5301682 (1994-04-01), Debbas
patent: 5314473 (1994-05-01), Godin
patent: 5336263 (1994-08-01), Ersek et al.
patent: 5451406 (1995-09-01), Lawin et al.
patent: 5480644 (1996-01-01), Freed
patent: 5490984 (1996-02-01), Freed
patent: 5580568 (1996-12-01), Greff et al.
patent: 5667767 (1997-09-01), Greff et al.
patent: 5695480 (1997-12-01), Evans et al.
patent: 5709657 (1998-01-01), Zimmon
patent: 5755658 (1998-05-01), Wallace et al.
patent: 5785642 (1998-07-01), Wallace et al.
patent: 5792478 (1998-08-01), Lawin et al.
patent: 5830178 (1998-11-01), Jones et al.
patent: 5861036 (1999-01-01), Godin
patent: 6098629 (2000-08-01), Johnson et al.
patent: 34223/95 (1996-05-01), None
patent: WO 97/19643 (1997-06-01), None
patent: WO 97/45131 (1997-12-01), None
patent: WO 98/01088 (1998-01-01), None
patent: WO 98/17200 (1998-04-01), None
patent: WO 98/17201 (1998-04-01), None
Donahue, P. et al., “Endoscopic Sclerosis Of The Gastric Cardia For Prevention Of Experimental Gastroesophageal Reflux” (1990)Gastrointestinal Endoscopy, pp. 253-258.
Society of Am. Gastrointestinal Endoscopic Surgeons, Los Angeles, CA, “Granting of Privileges for Laparascopic General Surgery”, (Mar. 1991),Am. Jrnl. of Surgery, vol. 161, pp. 324-325.
Aye, R.W. et al., “Early Results With the Laparoscopic Hill Repair”, (May 1994),Am. Jrnl. of Surgery, vol. 167, pp. 542-546.
Collard, J.M. et al., “Laparoscopic Antireflux Surgery/What is Real Progress?”, (1994),Annals of Surgery, vol. 220, No. 2, pp. 146-154.
DeMeester, T.R. et al., “Nissen Fundoplication for Gastroesophageal Reflux Disease”, (1986),Annals of Surgery, vol. 204, No. 1, pp. 9-20.
Donahue, P.E. et al., “The Floppy Nissen Fundoplication/Effective Long-term Control of Pathologic Reflux”, (Jun. 1985),Arch Surg, vol. 120, pp. 663-668.
Ellis, Jr., F.H., “The Nissen Fundoplication”, (1992),Ann. Thorac. Surg., vol. 54, pp. 1231-1235.
Grande, L. et al., “Value of Nissen fundoplication in patients with gastro-oesophageal reflux judged by long-term sympton control”, (1994),Brit. Jnl. of Surgery, vol. 81, pp. 548-550.
Hill, L.D. et al., “Laparoscopic Hill Repair”, (Jan. 1994),Contemporary Surgery, vol. 44, No. 1, pp. 13-20.
Hunter, J.G. et al., “A Physiologic Approach to Laparoscopic Fundoplication for Gastroesophageal Reflux Disease”, (1996),Annals of Surgery, vol. 223, No. 6, pp. 673-687.
Ireland, A.C. et al., “Mechanisms underlying the antireflux action of fundoplication”, (1993),Gut, vol. 34, pp. 303-308.
Johansson, J. et al., “Outcome 5 years after 360° fundoplication for gastro-oesophageal reflux disease”, (Jan. 1993),Brit. Jnl. of Surgery, vol. 80, pp. 46-49.
Kauer, W.K.H. et al., “Mixed Reflux of Gastric and Duodenal Juices Is More Harmful to the Esophagus than Gastric Juice Alone/The Need for Surgical Therapy Re-Emphasized”, (1995)Annals of Surgery, vol. 222, No. 4, pp. 525-533.
Klingman, R.R. et al., “The Current Management of Gastroesophageal Reflux”, (1991),Adv. Surg., vol. 24, pp. 259-291.
Little, A.G., “Mechanisms of Action of Antireflux Surgery: Theory and Fact”, (1992),World Jnl. of Surgery, vol. 16, pp. 320-325.
Luostarinen, M., “Nissen Fundoplication for Reflux Esophagitis/Long-Term Clinical and Endoscopic Results in 109 of 127 Consecutive Patients”, (1993),Annals of Surgery, vol. 217, No. 4, pp. 329-337.
Luostarinen, M. et al., “Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis”, (1993),Gut, vol. 34, pp. 1015-1020.
Malizia, A. et al.,
Silverman David E.
Stein Alan
Enteric Medical Technologies, Inc.
Flehr Hohbach Test Albritton & Herbert LLP
Szmal Brian
Winakur Eric F.
LandOfFree
Method for treating gastroesophageal reflux disease and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating gastroesophageal reflux disease and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating gastroesophageal reflux disease and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2499901